These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 4131117)
1. The folded conformation of the encephalitogenic protein of the human brain. Epand RM; Moscarello MA; Zierenberg B; Vail WJ Biochemistry; 1974 Mar; 13(6):1264-7. PubMed ID: 4131117 [No Abstract] [Full Text] [Related]
2. The ordered structure of the encephalitogenic protein from normal human myelin. Moscarello MA; Katona E; Neumann AW; Epand RM Biophys Chem; 1974 Oct; 2(3):290-5. PubMed ID: 4139983 [No Abstract] [Full Text] [Related]
3. The chemical and immunologic properties of the basic A1 protein of myelin. Eylar EH Adv Exp Med Biol; 1972; 32(0):215-40. PubMed ID: 4137244 [No Abstract] [Full Text] [Related]
4. Physical studies of myelin. I. Thermal analysis. Ladbrooke BD; Jenkinson TJ; Kamat VB; Chapman D Biochim Biophys Acta; 1968 Sep; 164(1):101-9. PubMed ID: 5680287 [No Abstract] [Full Text] [Related]
5. Phospholipase C (Bacillus cereus) digestion of phospholipids in myelin isolated from central nervous tissue: removal of myelin basic protein increases exposure of lipids to the enzyme. Gwarsha K; Rumsby MG; Little C Biochem Soc Trans; 1980 Oct; 8(5):600-1. PubMed ID: 6161042 [No Abstract] [Full Text] [Related]
6. The localization of the basic protein and N-2 in diseased myelin. Wood DD; Vail WJ; Moscarello MA Brain Res; 1975 Aug; 93(3):463-71. PubMed ID: 51672 [TBL] [Abstract][Full Text] [Related]
7. Effect of proteolytic attack on the structure of CNS myelin membrane. Wood JG; Dawson RM; Hauser H J Neurochem; 1974 May; 22(5):637-43. PubMed ID: 4407090 [No Abstract] [Full Text] [Related]
8. The stability of myelin ethanolamine glycerophosphatide in post-mortem human and bovine brains. Fewster ME; Hirono H; Mead JF J Neurochem; 1972 Jul; 19(7):1803-5. PubMed ID: 5065002 [No Abstract] [Full Text] [Related]
9. Polypeptide chains from porcine cerebral myelin. Reynolds JA; Green HO J Biol Chem; 1973 Feb; 248(4):1207-10. PubMed ID: 4119814 [No Abstract] [Full Text] [Related]
11. Structural insight into the role of myelin basic protein in multiple sclerosis. Husted C Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4339-40. PubMed ID: 16537365 [No Abstract] [Full Text] [Related]
12. Phospholipids in demyelinating diseases. Bukovský V; Dobrota D; Mézesová V Acta Univ Carol Med (Praha); 1987; 33(7-8):561-9. PubMed ID: 3455640 [No Abstract] [Full Text] [Related]
13. D-aspartic acid in purified myelin and myelin basic protein. Fisher GH; Garcia NM; Payan IL; Cadilla-Perezrios R; Sheremata WA; Man EH Biochem Biophys Res Commun; 1986 Mar; 135(2):683-7. PubMed ID: 2421722 [TBL] [Abstract][Full Text] [Related]
14. Isolation of purified basic protein from human brain. Banik NL; Davison AN J Neurochem; 1973 Sep; 21(3):489-94. PubMed ID: 4126357 [No Abstract] [Full Text] [Related]
15. Alterations of phospholipids, particularly plasmalogens, in the demyelination of multiple sclerosis as compared with that of cerebral oedema. Yanagihara T; Cumings JN Brain; 1969 Mar; 92(1):59-70. PubMed ID: 5774032 [No Abstract] [Full Text] [Related]
16. The isolation and characterization of an acid-soluble protein from myelin. Lowden JA; Moscarello MA; Morecki R Can J Biochem; 1966 May; 44(5):567-77. PubMed ID: 5961654 [No Abstract] [Full Text] [Related]
17. Enzymatic and nonenzymatic degradation of myelin basic protein. Deibler GE; Boyd LF; Kies MW Neurochem Res; 1984 Oct; 9(10):1371-85. PubMed ID: 6083465 [TBL] [Abstract][Full Text] [Related]